1. HSCT Seen as Superior to Current Therapies for Severe, Progressive Sclerosis
“Autologous hematopoietic stem cell transplantation (HSCT), evaluated in 18 people with rapidly progressing systemic sclerosis, found the experimental therapy superior to standard treatments for the disease for this patient population.”
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?